Captrust Financial Advisors Applied Genetic Technologies Corp Transaction History

Captrust Financial Advisors

  • $33 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
BUY
$1.07 - $2.71 $535 - $1,355
500 Added 20.0%
3,000 $3,000
Q3 2021

Nov 16, 2021
SELL
$3.01 - $4.12 $1,505 - $2,060
-500 Reduced 16.67%
2,500 $8,000
Q2 2021

Aug 16, 2021
BUY
$3.62 - $5.23 $9,050 - $13,075
2,500 Added 500.0%
3,000 $12,000
Q1 2021

May 17, 2021
BUY
$3.94 - $8.19 $1,970 - $4,094
500 New
500 $3,000

About APPLIED GENETIC TECHNOLOGIES CORP

AGTC Quotes by TradingView
  • Ticker AGTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,632,200
  • Description
  • Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...
More about AGTC
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email